200+ leading individuals in healthcare, life sciences and private equity gathered at the Shangri-La Hotel in Paris for the European Health & Life Sciences Symposium 2023 to enjoy a day packed with fireside chats, in-depth...more
11/28/2023
/ Artificial Intelligence ,
Capital Markets ,
Digital Health ,
EU ,
Healthcare ,
Information Technology ,
Investment ,
Investors ,
Life Sciences ,
Pharmaceutical Industry ,
Private Equity ,
Technology ,
UK
Please join McDermott for our highly anticipated Life Sciences Dealmaking Symposium! Now in its 12th year, the Symposium offers a unique platform for education, insight sharing, purposeful networking and strategic...more
10/23/2023
/ Acquisitions ,
Artificial Intelligence ,
Asset Valuations ,
Capital Markets ,
Capital Raising ,
Carve Out Provisions ,
Collaboration ,
Cross-Border Transactions ,
Events ,
Health Care Providers ,
Health Technology ,
Initial Public Offering (IPO) ,
Investors ,
IP License ,
IP Portfolio ,
Life Sciences ,
Mergers ,
Pharmaceutical Industry ,
Private Equity Firms ,
Publicly-Traded Companies ,
Special Purpose Acquisition Companies (SPACs)
We can't wait to see you in Paris at our second annual symposium. You'll meet with senior executives in the health, life sciences and private equity industries to identify new investment opportunities and position your...more
10/19/2023
/ Artificial Intelligence ,
Events ,
Financing ,
Health Care Providers ,
Health Information Technologies ,
Healthcare Facilities ,
Investment Opportunities ,
Investors ,
Life Sciences ,
Private Equity ,
Private Equity Firms ,
Private Equity Funds
As macroeconomic forces and geopolitical dynamics continue to shape the M&A and investment climate globally, health and life sciences transactions continue to remain high priority sectors presenting both high growth and...more
9/15/2023
/ Acquisitions ,
Austria ,
Capital Markets ,
Denmark ,
France ,
Germany ,
Global Market ,
Health Care Providers ,
Healthcare ,
Healthcare Reform ,
Investment ,
Investors ,
Italy ,
Jurisdiction ,
Life Sciences ,
Mergers ,
Netherlands ,
Poland ,
Regulatory Agenda ,
Spain ,
Switzerland ,
UK ,
United States
HPE Europe is back!
Join the biggest names in healthcare, life sciences and private equity for an unforgettable day of thought-provoking discussions, cutting-edge insights and valuable networking opportunities at the...more
8/16/2023
/ Artificial Intelligence ,
Digital Health ,
Events ,
Health Care Providers ,
Health Information Technologies ,
Health Technology ,
Healthcare Facilities ,
Investment Banks ,
Investment Opportunities ,
Investors ,
Life Sciences ,
Medical Devices ,
Pharmaceutical Industry ,
Private Equity ,
Private Equity Firms ,
Private Equity Funds
Come together with key decision-makers, innovators and investors from across the healthcare, life sciences and private equity (PE) industries during the year’s largest healthcare investment symposium....more
1/5/2023
/ Biopharmaceutical ,
Digital Health ,
Events ,
Health Care Providers ,
Health Technology ,
Healthcare Facilities ,
Hospitals ,
Investment Opportunities ,
Investors ,
Life Sciences ,
Pharmaceutical Industry ,
Physicians ,
Popular ,
Private Equity ,
Private Equity Firms ,
Telehealth
Key Trends & Opportunities in Life Sciences and Healthcare Investing -
The current macroeconomic environment is creating challenges for healthcare and life sciences businesses, which have been impacted hard by wage...more
12/9/2022
/ Capital Markets ,
Digital Health ,
EU ,
Healthcare ,
Investment ,
Investors ,
Life Sciences ,
Pharmaceutical Industry ,
Private Equity ,
Technology ,
UK
RUSSIA RESPONDS TO WESTERN SANCTIONS WITH PATENT RETALIATION -
On March 6, 2022, the Russian government retaliated against the West’s imposition of sanctions by issuing a decree permitting patented innovations to be used...more
6/27/2022
/ Appeals ,
Biotechnology ,
Cosmetics ,
Dietary Supplements ,
EU ,
France ,
Intellectual Property Protection ,
Medical Devices ,
Patent Litigation ,
Patent Validity ,
Patents ,
Pharmaceutical Industry ,
Russia ,
Sanctions ,
Trademark Litigation ,
Trademarks
Today’s global healthcare marketplace is marked by unprecedented transformation. This presents both challenges and opportunity to today’s market participants. We know how important it is to structure cross-border investments...more
6/1/2022
/ Anti-Kickback Statute ,
Artificial Intelligence ,
Cross-Border ,
Global Market ,
Healthcare ,
Investment ,
Investors ,
Life Sciences ,
Medical Technology Companies ,
Merger Controls ,
Pharmaceutical Industry ,
Technology Sector ,
Telemedicine
UNIFIED PATENT COURT -
The Unified Patent Court (UPC) should become a reality in 2022 or in the first few months of 2023.
The Protocol on Provisional Application (PPA) of the Agreement on a Unified Patent Court (AUPC)...more
2/21/2022
/ EU ,
France ,
Healthcare ,
Manufacturers ,
Medical Devices ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Trademarks ,
Unfair Competition
Patent and trademark issues effecting pharmaceutical laboratories, biotechs, food supplements and dietary products professionals, cosmetics companies and medical devices manufacturers is continually evolving across France and...more
9/29/2021
/ Counterfeiting ,
EU ,
France ,
Intellectual Property Protection ,
Inventions ,
Patent Infringement ,
Patent Invalidity ,
Patent Litigation ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Revocation ,
Trademark Infringement ,
Trademark Invalidity ,
Trademarks
This wide ranging discussion, sponsored by our Paris office, focuses on navigating cross border collaborations, insights for entering the US life sciences market as well as strategies for capitalizing on the growth of digital...more
Today’s global healthcare marketplace is marked by unprecedented transformation. The seismic shifts in healthcare delivery and drug development during COVID-19 have, in 2021, continued to demonstrate the power and capacity...more
9/20/2021
/ Austria ,
Cannabis Products ,
Clinical Trials ,
Coronavirus/COVID-19 ,
Data Protection ,
Denmark ,
Digital Health ,
EU ,
France ,
Germany ,
Healthcare ,
Information Technology ,
Investment ,
Italy ,
Medical Devices ,
Netherlands ,
Pharmaceutical Industry ,
Poland ,
Procurement Guidelines ,
Proposed Legislation ,
Spain ,
Supply Chain ,
Switzerland ,
Telemedicine ,
UK ,
UK Brexit ,
Whistleblowers
This year, recognising that as we are still unable to meet in person, our HPE Europe EVENT will be going ahead with two exclusive, virtual extended lunch time sessions.
We will be joined by investors including key players...more
6/9/2021
/ Acquisitions ,
Business Valuations ,
Coronavirus/COVID-19 ,
Financing ,
Health Care Providers ,
Healthcare Facilities ,
Hospitals ,
Investment Opportunities ,
Investors ,
Lenders ,
Leveraged Loans ,
Life Sciences ,
Mergers ,
Physicians ,
Private Equity ,
Private Equity Firms ,
Private Equity Funds ,
Risk Management ,
Webinars
Given the challenges of conducting clinical trials during the COVID-19 pandemic, many countries — including France — have allowed for some use of remote quality controls. In response to guidelines issued recently by European...more
5/5/2021
/ Clinical Trials ,
CNIL ,
Compliance ,
Coronavirus/COVID-19 ,
Data Protection ,
EU ,
France ,
Personal Data ,
Personally Identifiable Information ,
Policies and Procedures ,
Public Health Emergency ,
Quality Control Plan
In a year marked by unexpected challenges and rapid change, staying connected with industry peers and keeping a watchful eye on market trends, policy developments and collaborations in the life sciences space is crucial to...more
10/15/2020
/ Acquisitions ,
Collaboration ,
Coronavirus/COVID-19 ,
Cross-Border Transactions ,
Diagnostic Tests ,
Digital Health ,
Due Diligence ,
Early Stage Companies ,
Health and Safety ,
Health Care Providers ,
Healthcare Facilities ,
Infectious Diseases ,
Innovation ,
Investment Banks ,
Investors ,
Life Sciences ,
Mergers ,
Physicians ,
Presidential Elections ,
Startups ,
Telehealth ,
Telemedicine ,
Vaccinations ,
Webinars
In a year marked by unexpected challenges and rapid change, staying connected with industry peers and keeping a watchful eye on market trends, policy developments and collaborations in the life sciences space is crucial to...more
10/15/2020
/ Acquisitions ,
Collaboration ,
Coronavirus/COVID-19 ,
Cross-Border Transactions ,
Diagnostic Tests ,
Digital Health ,
Due Diligence ,
Early Stage Companies ,
Health and Safety ,
Health Care Providers ,
Healthcare Facilities ,
Infectious Diseases ,
Innovation ,
Investment Banks ,
Investors ,
Life Sciences ,
Mergers ,
Physicians ,
Presidential Elections ,
Startups ,
Telehealth ,
Telemedicine ,
Vaccinations ,
Webinars
In a year marked by unexpected challenges and rapid change, staying connected with industry peers and keeping a watchful eye on market trends, policy developments and collaborations in the life sciences space is crucial to...more
10/14/2020
/ Acquisitions ,
Collaboration ,
Coronavirus/COVID-19 ,
Cross-Border Transactions ,
Diagnostic Tests ,
Digital Health ,
Due Diligence ,
Early Stage Companies ,
Health and Safety ,
Health Care Providers ,
Healthcare Facilities ,
Infectious Diseases ,
Innovation ,
Investment Banks ,
Investors ,
Life Sciences ,
Mergers ,
Physicians ,
Presidential Elections ,
Startups ,
Telehealth ,
Telemedicine ,
Vaccinations ,
Webinars
In a year marked by unexpected challenges and rapid change, staying connected with industry peers and keeping a watchful eye on market trends, policy developments and collaborations in the life sciences space is crucial to...more
10/13/2020
/ Acquisitions ,
Collaboration ,
Coronavirus/COVID-19 ,
Cross-Border Transactions ,
Diagnostic Tests ,
Digital Health ,
Due Diligence ,
Early Stage Companies ,
Health and Safety ,
Health Care Providers ,
Healthcare Facilities ,
Infectious Diseases ,
Innovation ,
Investment Banks ,
Investors ,
Life Sciences ,
Mergers ,
Physicians ,
Presidential Elections ,
Startups ,
Telehealth ,
Telemedicine ,
Vaccinations ,
Webinars
In the second installment of McDermott’s webinar series, HPE Europe 2020: What are the Life Science Transaction Trends in the Wake of the Sanitary Crisis?, moderator and McDermott partner Emmanuelle Trombe and industry...more
The Legal Impact in Europe on Pharmaceutical and Medical Device Companies -
The current crisis mode has triggered legal and commercial issues that affect the pharmaceutical and medical device industry across...more
5/27/2020
/ Coronavirus/COVID-19 ,
Cybersecurity ,
Data Protection ,
EU ,
European Commission ,
European Competition Network (ECN) ,
Exports ,
Force Majeure Clause ,
Homeland Security Cybersecurity & Infrastructure Security Agency (CISA) ,
Imports ,
Intellectual Property Protection ,
Manufacturers ,
Medical Devices ,
Pharmaceutical Industry ,
Remote Working ,
UK ,
Wine & Alcohol
Across the US and EU, life sciences companies are pushing diagnostics, antibody testing, vaccines and other efforts forward to flatten the Coronavirus (COVID-19) curve. Our multidisciplinary cross-border life sciences team...more
5/5/2020
/ Acquisitions ,
Contact Tracing ,
Coronavirus/COVID-19 ,
Cross-Border Transactions ,
Diagnostic Tests ,
Digital Health ,
Divestiture ,
Due Diligence ,
Foreign Investment ,
Health Care Providers ,
Intellectual Property Protection ,
Joint Venture ,
Life Sciences ,
Medical Testing ,
Mergers ,
Partnerships ,
Pharmaceutical Industry ,
Regulatory Oversight ,
Vaccinations ,
Virus Testing ,
Webinars
From the rise of digital health opportunities to concerns stemming from political shifts, McDermott partners review major European health trends in 2019 and look forward to what we might expect to see from 2020 onwards....more
Data Inspections in China: Increased Supervision and Compliance -
Data protection inspections have become more frequent for companies with operations in China. Many companies are struggling for guidance on how to...more
The Impact of The EU General Data Protection Regulation -
The EU General Data Protection Regulation 2016/679 (GDPR) was published in the Official Journal of the European Union on 4 May 2016 following the compromise...more
8/31/2016
/ Acquisitions ,
Antitrust Litigation ,
Carry Forward ,
CFIUS ,
Cross-Border Transactions ,
Data Privacy ,
Data Protection ,
Data Protection Officers (DPOs) ,
EBITDA ,
EU ,
General Data Protection Regulation (GDPR) ,
Interest Income ,
life ,
Life Sciences ,
Mergers ,
Oil & Gas ,
Outsourcing ,
Personal Data ,
Publicly-Traded Companies ,
Tax Code ,
Tax Deductions ,
UK ,
UK Brexit